Aldosterone antagonism in heart failure: improvement of cardiac remodelling, endothelial dysfunction and platelet activation

This publication has 25 references indexed in Scilit:

• Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction
  The American Journal of Cardiology, 2004
• Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction
  Circulation, 2003
• Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 2003
• Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart
  Clinical Science, 2002
• Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression
  Journal of the American College of Cardiology, 2002
• Striking Increase of Natriuresis by Low-Dose Spironolactone in Congestive Heart Failure Only in Combination With ACE Inhibition
  Circulation, 2000
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
  The American Journal of Cardiology, 1995
• Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril
  Journal of the American College of Cardiology, 1994
• ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
  Published by Elsevier ,1987